2013

Macrocycles: Discovery, Development & Technologies

September 2013
Insight Pharma Reports

From $1,595.00

Molecular Biomarkers for Cancer Detection and Management

July 2013
Insight Pharma Reports

From $1,595.00

Digital PCR Technology Report

June 2013
Insight Pharma Reports

From $1,595.00

Consensus Outlook: Prostate Cancer

May 2013

From $4,995.00

Companion Diagnostics and Other Aspects of Personalized Medicine

May 2013
Insight Pharma Reports

From $2,495.00

Advances in Clinical Genome Sequencing and Diagnostics

March 2013
Insight Pharma Reports

From $2,495.00

Report Topics